Min Yang
About Min Yang
Min Yang serves as the Head of Translational Medicine at Evelo Biosciences, a position held since 2020. Previously, Yang was the Executive Director of Translational Research at Leap Therapeutics from 2018 to 2020.
Work at Evelo Biosciences
Min Yang has been serving as the Head of Translational Medicine at Evelo Biosciences since 2020. In this role, Yang focuses on bridging the gap between preclinical research and clinical development. The position involves overseeing the translational research efforts to ensure that innovative therapies are effectively developed and brought to clinical trials. Evelo Biosciences is located in Cambridge, Massachusetts, where Yang continues to contribute to the advancement of therapeutic solutions.
Previous Experience at Leap Therapeutics
Prior to joining Evelo Biosciences, Min Yang worked at Leap Therapeutics as the Executive Director of Translational Research from 2018 to 2020. During this two-year tenure in Cambridge, MA, Yang was responsible for leading translational research initiatives. This role involved developing strategies to translate scientific discoveries into viable clinical applications, enhancing the company's research capabilities.
Education and Expertise
Min Yang possesses a strong background in translational medicine and research. The expertise gained through years of experience in the biotechnology sector enables Yang to effectively lead teams and projects focused on the development of new therapies. This expertise is crucial for navigating the complexities of translating preclinical findings into successful clinical outcomes.
Professional Background
Min Yang has built a career in the biotechnology and pharmaceutical industries, with a focus on translational research. The professional journey includes significant roles that emphasize the importance of translating scientific research into practical medical applications. Yang's experience spans various aspects of drug development, from preclinical studies to clinical trial design.